upadacitinib
abbvie
['upadacitinib', 'ulcerative colitis']
new #acg2022 data shows upadacitinib continues to be a top choice in treating patients with ulcerative colitis. 
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.